PROTO AXIOM
Australia produces world leading intellectual property in drug development and medical equipment, yet captures virtually none of the downstream commercialisation and job multipliers. This is in part due to underdeveloped domestic preclinical expertise. Proto Axiom on shores this capacity, keeping Australian IP in Australia.
PROTO AXIOM
Industry:
Biotechnology Life Science Venture Capital
Founded:
2021-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Apps For Business Wix Hosted
Current Advisors List
Current Employees Featured
Founder
More informations about "Proto Axiom"
Proto Axiom - Australian biotech investment incubator
Proto Axiom is an investment company with an incubation arm. This structure provides us with the flexibility to construct a portfolio of the best, most innovative businesses in biotechnology. …See details»
Proto Axiom | Endo Axiom
Endo Axiom is supported by venture capital provided by Proto Axiom. Proto Axiom is Australia's pre-emine nt biotechnology incubator i nvesting in pre-clinical research. Proto Axiom focuses on capturing Australia’s world leading …See details»
Proto Axiom - Crunchbase Investor Profile & Investments
Proto Axiom on shores this capacity, keeping Australian IP in Australia. Lists Featuring This Company. Edit Lists Featuring This Company Section. Australia Startups . 2,945 Number of …See details»
Proto Axiom Secures $20M to Boost Australia’s Biotech …
Dec 5, 2024 Established in 2021 by CEO Anthony Liveris and Chairman Tristan Edwards, Proto Axiom focuses on supporting early-stage biotech ventures through resources, mentorship, and funding. The incubator distinguishes itself …See details»
Biotech incubator Proto Axiom raises $20m in Series B round
Aug 13, 2024 The latest raise, coupled with a $15 million Series A announced in September last year, gives the Sydney-based Proto Axiom a cash value of $90 million. Proto Axiom says …See details»
Proto Axiom Pty Ltd - VentureRadar
Proto Axiom is Australia's pioneering biotech incubator and investment firm, dedicated to fostering medical innovation through funding and pre-clinical research. By supporting early-stage …See details»
Meet the Team - Proto Axiom
Guided by a collective wealth of industry insight and strategic acumen, our seasoned team of professionals fuels the transformative vision of Proto Axiom, propelling us toward a future …See details»
Proto Axiom Secures $20 Million in Series B Funding to Boost …
Proto Axiom is thrilled to announce the successful raise of $20 million, marking a significant milestone in our mission to revitalize scientific innovation in Australia. With a deep-rooted …See details»
ProtoAxiom | Catalio Capital Portfolio
ProtoAxiom is a biotech incubator identifying and evaluating promising pre-clinical assets in Australian universities and advancing them to clinical trials.See details»
Series A - Proto Axiom - 2022-09-27 - Crunchbase
Jan 27, 2023 Organization Name . Proto Axiom . Announced Date Sep 27, 2022; Closed On Date Jan 27, 2023; Funding Type Series A; Funding Stage Early Stage Venture; Money …See details»
Proto Axiom Secures $20M in Series B to Strengthen Australia's …
Aug 13, 2024 Proto Axiom, the Australian biomedical technology incubator has today announced a $20 million first close of its targeted $30 million Series B, to bolster Australia's biotechnology …See details»
Membership - Proto Axiom
Proto Axiom's Researcher Network provides member institutes, researchers and entrepreneurs to exclusive access to our incubation platform. Our hands-on approach provides access to …See details»
Australian Biomedical Technology Incubator Proto Axiom raises …
May 1, 2023 Technode Global - Aprin 17th, 2023Australian biomedical technology incubator Proto Axiom has on Monday announced a second round of financing of $5 million, after its …See details»
Biotech incubator Proto Axiom banks $20 million towards $30m …
Aug 13, 2024 Biomedical technology incubator Proto Axiom has raised $20 million in the first close of a planned $30m Series B. The company did not name its latest backers, who join the …See details»
Proto Axiom secures $20 million in Series B funding to support ...
Aug 13, 2024 Proto Axiom, an Australian biomedical technology incubator, has announced a $20 million first close of its targeted $30 million Series B funding, bringing its cash value to $90 …See details»
Australian biotech incubator Proto Axiom announces $20M
Aug 13, 2024 $20M unlocked for opportunities in Australian biotech innovation, valuing Proto Axiom at $90M. SYDNEY, Aug. 13, 2024 /PRNewswire/ -- Proto Axiom, the Australian …See details»
Biotech incubator Proto Axiom banks $20 million towards $30m …
Proto Axiom set out to help keep intellectual property (IP) in drug development and medical equipment in Australia, rather than seeing it commercialised offshore. It was cofounded in …See details»
Australian biotechnology incubator Proto Axiom completes initial ...
Proto Axiom was co-founded by Catalio Capital Management. “Australia is unique in the contrast between its impressive level of IP creation and comparatively low level of development. …See details»
News - Proto Axiom
A Ground-Breaking Approach To Biotech Innovation, with Anthony Liveris, CEO of Proto Axiom. Australian biotechnology incubator Proto Axiom completes initial fundraising. Proto Axiom. …See details»
Membership Application - Proto Axiom
Proto Axiom's Researcher Network provides member institutes, researchers and entrepreneurs to exclusive access to our incubation platform. Our hands-on approach provides access to …See details»